Gland Pharma Limited (NSE:GLAND)

Gland Pharma Revenue

Gland Pharma had revenue of 19.03B INR in the quarter ending September 30, 2026, with 27.96% growth. This brings the company's total for the last twelve months to 70.61B, up 21.70% year-over-year. In the fiscal year ending March 31, 2026, Gland Pharma had annual revenue of 64.31B with 14.50% growth. That makes Gland Pharma the 9,041st largest company in the world by revenue and 367th in India.

• Revenue (ttm): 70.61B
• Revenue Growth: +21.70%
• P/S Ratio: 7.75
• Revenue / Employee: 16.30M
• Employees: 4,332
• Market Cap: 546.86B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• USA 31.19B 48.5%
• Europe 14.11B 21.9%
• Rest of World (ROW) 11.17B 17.4%
• India 5.51B 8.6%
• Canada 1.40B 2.2%
• Australia 851.32M 1.3%
• New Zealand 77.11M 0.1%

Fiscal year ended Mar 31, 2026 See the full Gland Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	64.31B	8.14B	14.50%
Mar 31, 2025	56.17B	-482.18M	-0.85%
Mar 31, 2024	56.65B	20.40B	56.29%
Mar 31, 2023	36.25B	-7.76B	-17.64%
Mar 31, 2022	44.01B	9.38B	27.08%

Data Source: S&P Global Market Intelligence Last updated: Nov 6, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error